Next

GRAPHICS

UTILITY OF AN ORAL PRESENTATION OF hCG (human Choriogonadotropin) FOR THE MANAGEMENT OF OBESITY. A DOUBLE-BLIND STUDY (III)

Figure 3 (A,B and C):Skinfold thickness reduction on three out of five "low-responsive" skinfolds

Simultaneously with bioelectrical impedance and anthropometrical assessments, we examined subcutaneous fat stores by plicometries. Results are expressed in mm, means ± SD (at top). Only Tricipital (see panel A) and Subscapular (see panel B) skinfold assessments demonstrated significant or nearly significant differences by comparing group G2 and the control P for the effect of TREATMENT or the INTERACTION (see statistical analysis details in the text).

It is also shown the data obtained for Suprailiac (see panel C) skinfold. Concerning these series of low responsive skinfolds, no relevant difference between groups was raised after pairwise comparisons of each treatment weeks' record with its corresponding basal value: by Scheffé test, * p<0.03, ** p<0.0005

figure7.gif (7565 bytes)

(Click to enlarge)

figure8.gif (7926 bytes)

(Click to enlarge)

figure9.gif (6343 bytes)

(Click to enlarge)

The hCG and obesity  Research Clinic
Director: Dr. Daniel Belluscio
Phone and Fax+54-11-4804 97 84
Phone+54-11-4807 18 83

Proceedings of the First International Workshop on hCG and obesity
(click here)


 




Copyright © Dr. Daniel Belluscio 1992-2009. All rights reserved



Supervised the translation and spelling of this website

15/08/2009